RT Journal Article SR Electronic T1 Plant proteinase inhibitor from Enterolobium contortisiliquum (EcTI) attenuates elastase-induced pulmonary inflammatory, remodeling and mechanical alterations in mice JF European Respiratory Journal JO Eur Respir J FD European Respiratory Society SP P828 VO 40 IS Suppl 56 A1 Osmar A. Theodoro-Junior A1 Ricardo Henrique Marques A1 Rafael Almeida-Reis A1 Bruno T. Martins-Oliveira A1 Leandro V. Oliva A1 Tales Lopes A1 Carla M. Prado A1 Maria L.V. Oliva A1 Milton Martins A1 Iolanda F.L.C. Tibério YR 2012 UL http://erj.ersjournals.com/content/40/Suppl_56/P828.abstract AB Aims: to evaluate if a plant Kunitz proteinase inhibitor EcTI contributes to inactivation of elastase-induced mechanical, inflammatory and remodelling alterations. Methods: C57Bl6 mice received elastase (E group). Control group received saline (Ve group). Mice were treated with EcTI (2mg/kg) on days 1, 14 and 21 after elastase instillation (I-E group). On day 30, mice were anesthetized, mechanically ventilated and we analyzed respiratory system resistance (Rrs) and elastance (Ers), tissue elastance (Htis), tissue damping (Gtis), airway resistance (Raw) and exhaled nitric oxide (ENO). Bronchoalveolar lavage fluid (BALF) was performed, lungs were removed and by morphometry, we quantified the mean linear intercept (Lm), collagen and elastic fibers in lung parenchyma. Results: In E-group there was a significant increase in the Ers, Rrs, Raw, Htis, Lm, ENO, total cells and macrophages,neutrophils and lymphocytes in BALF, elastic and collagen fibres compared to controls (p<0.05). In I-E group there was a decreased in Lm (57.63±5.2µm), Raw (0.29±0.05cmH2O/ml/s), Ers (34.71±3.16cmH2O/L), Htis (36.30±4.42cmH2O/mL/s), macrophages (94.86±2.36%), neutrophils (3.29±2.31%), and lymphocytes (0.91±0.28%) in the BALF, ENO (31.67±2.23ppb) and collagen fibers (0.69%±0.04%) compared to E-group (p<0.05). Conclusions: This proteinase inhibitor (EcTI) reduced elastase-induced pulmonary inflammatory, remodeling and mechanical alterations induced by elastase. Although more studies need to be performed, this inhibitor may contribute as potential therapeutic tool for COPD management. Financial Support: FAPESP, CNPq, LIM-20 HCFMUSP.